Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

Arthritis Care and Research

Volumn 68, Issue 5, 2016, Pages 667-672

  De Lautour, Hugh ^a   Taylor, William J ^b   Adebajo, Ade ^c   Alten, Rieke ^d   Burgos Vargas, Ruben ^e   Chapman, Peter ^f   Cimmino, Marco A ^g   Da Rocha Castelar Pinheiro, Geraldo ^h   Day, Ric ⁱ   Harrold, Leslie R ^j   Helliwell, Philip ^k   Janssen, Matthijs ^l   Kerr, Gail ^m   Kavanaugh, Arthur ⁿ   Khanna, Dinesh ^o   Khanna, Puja P ^p   Lin, Chingtsai ^q   Louthrenoo, Worawit ^r   McCarthy, Geraldine ^s   Vazquez Mellado, Janitzia ^e   Mikuls, Ted R ^t   Neogi, Tuhina ^u   Ogdie, Alexis ^v   Perez Ruiz, Fernando ^w   Schlesinger, Naomi ^x   Ralph Schumacher, H ^v   Scirè, Carlo A ^y   Singh, Jasvinder A ^z   Sivera, Francisca ^aa   Slot, Ole ^ab   Stamp, Lisa K ^ac   Tausche, Anne Kathrin ^ad   Terkeltaub, Robert ^ae   Uhlig, Till ^af   Van De Laar, Mart ^ag   White, Douglas ^ah   Yamanaka, Hisashi ^ai   Zeng, Xuejun ^aj   Dalbeth, Nicola ^a   more..

^a AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e HOSPITAL GENERAL DE MÉXICO   (Mexico)

^f CHRISTCHURCH HOSPITAL   (New Zealand)

^g UNIVERSITY OF GENOA   (Italy)

^h HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF LEEDS   (United Kingdom)

^l RIJNSTATE HOSPITAL   (Netherlands)

^m VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF MICHIGAN   (United States)

^p VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^q TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^r Faculty of Medicine Chiang Mai University   (Thailand)

^s MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^t UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^u BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v UNIVERSITY OF PENNSYLVANIA   (United States)

^w HOSPITAL DE CRUCES   (Spain)

^x ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^y UNIVERSITY OF PAVIA   (Italy)

^z UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^aa Department of Rheumatology Hospital General Universitario Elda   (Spain)

^ab GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^ac UNIVERSITY OF OTAGO   (New Zealand)

^ad UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^ae UNIVERSITY OF CALIFORNIA   (United States)

^af DIAKONHJEMMET HOSPITAL   (Norway)

^ag UNIVERSITY OF TWENTE   (Netherlands)

^ah UNIVERSITY OF AUCKLAND   (New Zealand)

^ai TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^aj PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

URATE; URIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTER PROGRAM; CONSENSUS DEVELOPMENT; DELPHI STUDY; DISEASE ACTIVITY; EXPERIMENTAL STUDY; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; GOUT; HEALTH SURVEY; HUMAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL EXPERT; PAIN ASSESSMENT; QUESTIONNAIRE; REMISSION; TREATMENT RESPONSE; URIC ACID BLOOD LEVEL; BLOOD; CONSENSUS; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STANDARDS; SYMPTOM ASSESSMENT; TIME FACTOR;

CONSENSUS; DELPHI TECHNIQUE; GOUT; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; SYMPTOM ASSESSMENT; TIME FACTORS; URIC ACID;

EID: 84964432661     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22741     Document Type: Article

References (20)

1. Schumacher R., The pathogenesis of gout. Cleve Clin J Med 2008; 75: S2-4.
2. Rees F, Hul M, Doherty M., Optimizing current treatment of gout. Nat Rev Rheumatol 2014; 10: 271-83.
3. Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al., 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012; 64: 1431-46.
4. Sivera F, Andres M, Carmona L, Kydd AS, Moi J, Seth R, et al., Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 2014; 73: 328-55.
5. Taylor W., Measurement of outcome in gout. Ind J Rheumatol 2013; 8: S11-5.
6. Grainger R, Taylor W., Establishing outcome domains for evaluating treatment of acute and chronic gout. Curr Opin Rheumatol 2008; 20: 173-8.
7. Grainger R, Taylor W, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, et al., Progress in measurement instruments for acute and chronic gout studies. J Rheumatol 2009; 36: 2346-55.
8. Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, et al., OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol 2014; 41: 569-73.
9. Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, et al., Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 2011; 38: 1452-7.
10. Dalbeth N, McQueen FM, Singh JM, MacDonald PA, Edwards NL, Schumacher HR, et al., Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol 2011; 38: 1458-61.
11. Scire CA, Viroli C, Manara M, Cimmino MA, Govoni M, Salaffi F, et al., Development and preliminary validation of a candidate disease activity score for gout [abstract]. Ann Rheum Dis 2013; 72: 48.
12. Taylor WJ, Brown M, Aati O, Weatherall M, Dalbeth N., Do patient preferences for core outcome domains for chronic gout studies support the validity of composite response criteria? Arthritis Care Res (Hoboken) 2013; 65: 1259-64.
13. Bykerk VP, Massarotti EM., The new ACR/EULAR remission criteria: rationale for developing new criteria for remission. Rhematology (Oxford) 2012; 51: vi16-20.
14. Survey Monkey. 2014. URL: www.surveymonkey.com.
15. 1000Minds. 2014. URL: www.1000Minds.com.
16. Taylor WJ, Schumacher HR, Baraf HS, Chapman P, Stamp L, Doherty M, et al., A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis 2008; 67: 888-91.
17. Prowse RL, Dalbeth N, Kavanaugh A, Adebajo AO, Gaffo AL, Terkeltaub R, et al., A Delphi exercise to identify characteristic features of gout: opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol 2013; 40: 498-505.
18. Taylor WJ, Singh JA, Saag K, Dalbeth N, MacDonald PA, Edwards NL, et al., Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol 2011; 38: 1467-70.
19. Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, et al., Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 2010; 62: 1549-56.
20. Aati O, Taylor WJ, Siegert RJ, Horne A, House ME, Tan P, et al., Development of a patient-reported outcome measure of tophus burden: the tophus impact questionnaire (TIQ-20). Ann Rheum Dis 2014; 74: 2144-50.